Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.73), $0.08 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.